Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Patient-Tailored Measurable Residual Disease Monitoring in Peripheral Blood Using Deep Sequencing and Droplet Digital PCR for Early Detection of Relapse in Childhood Acute Myeloid Leukemia: A NOPHO-DBH Collaborative Study

Anne-Sofie Skou, Kristian Løvvik Juul-Dam, Erik Delsing Malmberg, Anna Rehammar, Anastasia Soboli, Azadeh Anbarlou, Erik Kristiansson, Jonas Abrahamsson, Bernward Zeller, Kirsi Jahnukainen, Edwin Sonneveld, Birgitte Lausen, Anni Aggerholm, Hans Beier Ommen, Henrik Hasle, Linda Fogelstrand

Blood (2021) 138 (Supplement 1): 3457.

https://doi.org/10.1182/blood-2021-153411

Published: 2021

Journal Articles

Clonal Hematopoiesis Drives Therapy-Related Myeloid Neoplasms Following Autologous Stem Cell Transplantation and Propagates during Disease Evolution

Johannes Frasez Sørensen, Anni Aggerholm, Marcus H Hansen, MSc, Gitte Birk Kerndrup, MD DMSc, Lene Hyldahl Ebbesen, MD PhD, Peter Hokland, MD DMSc, Anne Stidsholt Roug, MD PhD, Maja Ludvigsen, MSc, PhD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-141993

Published: 2020

Journal Articles

Patient-Tailored Deep Sequencing of Peripheral Blood Enables Early Detection of Relapse in Childhood Acute Myeloid Leukemia

Kristian Løvvik Juul-Dam, MD, Erik Delsing Malmberg, Anna Rehammar, Erik Kristiansson, Jonas Abrahamsson, Anni Aggerholm, Marta Maria Dirdal, Kirsi Jahnukainen, Birgitte Lausen, Hans Beier Ommen, Henrik Hasle, Linda Fogelstrand

Blood (2019) 134 (Supplement_1): 1456.

https://doi.org/10.1182/blood-2019-124970

Published: 2019

Journal Articles

Post-Therapy Measurable Residual Disease Monitoring in Peripheral Blood Using Overexpressed Genes in Childhood Acute Myeloid Leukemia

Anne-Sofie Skou, MD, Kristian Juul-Dam, MD, Maria Hansen, PhD MSc, Anni Aggerholm, MSc, PhD, Birgitte Lausen, MD PhD, Charlotte Guldborg Nyvold, Hans Beier Ommen, MD PhD, Henrik Hasle, MD

Blood (2018) 132 (Supplement 1): 1480.

https://doi.org/10.1182/blood-2018-99-110014

Published: 2018

Journal Articles

Therapy-Related Myeloid Neoplasms Following Autologous Stem Cell Transplantation: The Prevalence of Chip Mutations at Time of Transplantation — a Single Center Experience

Johannes Frasez Soerensen, Anni Aggerholm, MSc, PhD, Gitte Birk Kerndrup, MD DMSc, Marcus C Hansen, MSc, Ina Kathrine Lykke Ewald, Lene Hyldahl Ebbesen, MD PhD, Carina A Rosenberg, MSc, PhD, Peter Hokland, MD DMSc, Anne Stidsholt Roug, MD Ass. Prof, Maja Ludvigsen, MSc, PhD

Blood (2018) 132 (Supplement 1): 1529.

https://doi.org/10.1182/blood-2018-99-114482

Published: 2018

Journal Articles

Whole Genome Amplification and Exome Sequencing at the Single Cell Level - a Way to Address Clonal Heterogeneity and Very Sparse Clinical Material

Peter Hokland, MD DMedSc, Professor, Anita T Simonsen, MSc, PhDStud., Marcus Celik Hansen, MSc, Biomedical Engineer, Johnny Juhl Hindkjær, MSc, PhD, Anni Aggerholm, PhD MSc

Blood (2016) 128 (22): 1671.

https://doi.org/10.1182/blood.V128.22.1671.1671

Published: 2016

Journal Articles

Potential of Digital PCR in CML Calibration

Niels Pallisgaard, Morten T. Andersen, Anni Aggerholm, PhD, Hans Ehrencrona, MD PhD, Beatriz Bellosillo, Elisabeth Oppliger Leibundgut, PharmD

Blood (2014) 124 (21): 1817.

https://doi.org/10.1182/blood.V124.21.1817.1817

Published: 2014

Journal Articles

Allelic Methylation Levels of VTRNA2-1 Predict Outcome in Higher Risk MDS Patients Not Treated by Azacytidine.

Marianne B. Treppendahl, MD, Magnus Tobiasson, MD, Anni Aggerholm, PhD, Mohsen Karimi, PhD, Trine Silkjaer, MD, Lone S. Friis, MD, PhD, Mette K. Andersen, PhD, Lars Kjeldsen, MD, PhD, Mette S. Holm, MD, PhD, Eva Hellström-Lindberg, PhD, Kirsten Grønbæk, MD, DMSc

Blood (2012) 120 (21): 2394.

https://doi.org/10.1182/blood.V120.21.2394.2394

Published: 2012

Journal Articles

Genetic and Epigenetic Events in Childhood AML - Similarities and Differences with Adult AML.

Caroline Juhl-Christensen, MD, PhD, Hans Beier Ommen, MD, PhD, Anni Aggerholm, PhD, Birgitte Lausen, MD, PhD, Eigil Kjeldsen, MD, Henrik Hasle, MD, PhD, Peter Hokland, MD, DMSc

Blood (2009) 114 (22): 2396.

https://doi.org/10.1182/blood.V114.22.2396.2396

Published: 2009

Journal Articles

Mutations in Mitochondrial DNA Is An Adverse Factor for Survival in Patients with Acute Myeloid Leukemia.

Trine Silkjaer, Anni Aggerholm, Charlotte Guldborg Nyvold, Peter Hokland, M.D., Jan Maxwell Norgaard

Blood (2008) 112 (11): 1523.

https://doi.org/10.1182/blood.V112.11.1523.1523

Published: 2008

Journal Articles

Expression Patterns of Hoxa4 and Meis1 Genes Are Regulated by Promoter Hypermethylation and When Combined Predict Survival in AML.

Lykke Christina Grubach, MSc, Mike Zangenberg, Hans Beier Ommen, M.D., Anni Aggerholm, Peter Hokland, M.D.

Blood (2008) 112 (11): 1204.

https://doi.org/10.1182/blood.V112.11.1204.1204

Published: 2008

Journal Articles

Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndr–ome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy

Michael Grövdal, Rasheed Khan, Anni Aggerholm, Petar Antunovic, Jan Astermark, Per Bernell, Lena-Maria Engström, Lars Kjeldsen, Olle Linder, Lars Nilsson, Anna Olsson, Jonas Wallvik, Jon Magnus Tangen, Gunnar Öberg, Sten Eirik Jacobsen, Anna Porwit, Peter Hokland, Eva Hellström-Lindberg

Blood (2008) 112 (11): 223.

https://doi.org/10.1182/blood.V112.11.223.223

Published: 2008

Journal Articles

Maintenance Treatment with Azacytidine for Patients with High Risk Myelodysplastic Syndromes or Acute Myeloid Leukaemia in Complete Remission after Intensive Chemotherapy.

Michael Grövdal, Rasheed Khan, Anni Aggerholm, Petar Antunovic, Jan Astermark, Per Bernell, Lena-Maria Engström, Lars Kjeldsen, Olle Linder, Lars Nilsson, Anna Olsson, Jonas Wallvik, Jon Magnus Tangen, Gunnar Öberg, Sten Eirik Jacobsen, Peter Hokland, Anna Porwit, Eva Hellström-Lindberg

Blood (2007) 110 (11): 818.

https://doi.org/10.1182/blood.V110.11.818.818

Published: 2007

Journal Articles

Delineation of Promoter Methylation in Patients with Myelodysplastic Syndromes: Widespread and Concurrent Hypermethylation of Multiple Genes and Increased mRNA Expression of the DNA Methyltransferases DNMT1, 3A and 3B.

Anni Aggerholm, PhD, Mette S. Holm, MD, PhD, Per Guldberg, PhD, Peter Hokland, MD DMedSci

Blood (2004) 104 (11): 472.

https://doi.org/10.1182/blood.V104.11.472.472

Published: 2004

Journal Articles

Evidence for T-Cell Involvement in MDS: Similar Patterns of Hypermethylation of Key Genes in Purified CD34+ and CD3+ Cell Fractions in an RAEB Patient.

Anni Aggerholm, PhD, Anita Rethmeier, PhD, Per Guldberg, PhD, Ingrid Carlsen, MedTech, Karin Brændstrup, MedTech, Peter Hokland, MD, DMedSci

Blood (2004) 104 (11): 4712.

https://doi.org/10.1182/blood.V104.11.4712.4712

Published: 2004

Journal Articles

Promoter Hypermethylation and Quantitative mRNA Expression of the Retinoic Acid Receptor β2 Gene in Patients with Acute Myeloid Leukemia.

Anita Rethmeier, MSc, Peter Hokland, DMedSci, Anni Aggerholm, PhD

Blood (2004) 104 (11): 1065.

https://doi.org/10.1182/blood.V104.11.1065.1065

Published: 2004

Journal Articles

DAP-kinase CpG island methylation in acute myeloid leukemia: methodology versus biology?

Anni Aggerholm, Peter Hokland, Per Guldberg

Blood (2000) 95 (9): 2997–2999.

https://doi.org/10.1182/blood.V95.9.2997.009k40d_2997_2999

Published: 2000

NARROW

Patient-Tailored Measurable Residual Disease Monitoring in Peripheral Blood Using Deep Sequencing and Droplet Digital PCR for Early Detection of Relapse in Childhood Acute Myeloid Leukemia: A NOPHO-DBH Collaborative Study

Clonal Hematopoiesis Drives Therapy-Related Myeloid Neoplasms Following Autologous Stem Cell Transplantation and Propagates during Disease Evolution

Patient-Tailored Deep Sequencing of Peripheral Blood Enables Early Detection of Relapse in Childhood Acute Myeloid Leukemia

Post-Therapy Measurable Residual Disease Monitoring in Peripheral Blood Using Overexpressed Genes in Childhood Acute Myeloid Leukemia

Therapy-Related Myeloid Neoplasms Following Autologous Stem Cell Transplantation: The Prevalence of Chip Mutations at Time of Transplantation — a Single Center Experience

Whole Genome Amplification and Exome Sequencing at the Single Cell Level - a Way to Address Clonal Heterogeneity and Very Sparse Clinical Material

Potential of Digital PCR in CML Calibration

Allelic Methylation Levels of VTRNA2-1 Predict Outcome in Higher Risk MDS Patients Not Treated by Azacytidine.

Genetic and Epigenetic Events in Childhood AML - Similarities and Differences with Adult AML.

Mutations in Mitochondrial DNA Is An Adverse Factor for Survival in Patients with Acute Myeloid Leukemia.

Expression Patterns of Hoxa4 and Meis1 Genes Are Regulated by Promoter Hypermethylation and When Combined Predict Survival in AML.

Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndr–ome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy

Maintenance Treatment with Azacytidine for Patients with High Risk Myelodysplastic Syndromes or Acute Myeloid Leukaemia in Complete Remission after Intensive Chemotherapy.

Delineation of Promoter Methylation in Patients with Myelodysplastic Syndromes: Widespread and Concurrent Hypermethylation of Multiple Genes and Increased mRNA Expression of the DNA Methyltransferases DNMT1, 3A and 3B.

Evidence for T-Cell Involvement in MDS: Similar Patterns of Hypermethylation of Key Genes in Purified CD34+ and CD3+ Cell Fractions in an RAEB Patient.

Promoter Hypermethylation and Quantitative mRNA Expression of the Retinoic Acid Receptor β2 Gene in Patients with Acute Myeloid Leukemia.

DAP-kinase CpG island methylation in acute myeloid leukemia: methodology versus biology?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only